10-K Decoder · All companies

Emergent BioSolutions Inc.

EBS · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$743M$1.04B−28.8%
Operating income$100M−$109M
Net income$52.6M−$191M

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 3, 2026

$Q3 2026Year earlierChange
Revenue$110M$231M−52.4%
Operating income−$37.3M$76.5M
Net income−$32.7M$51.2M

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Emergent BioSolutions's revenue in FY2025?
$743M in FY2025 (Fiscal year ended Dec 31, 2025), −28.8% vs $1.04B a year earlier, per its 10-K filed Feb 2026.
Was Emergent BioSolutions profitable in FY2025?
Yes: net income was $52.6M and operating income $100M in FY2025.
What was Emergent BioSolutions's revenue in Q3 2026?
$110M (−52.4% vs a year earlier), per its Form 10-Q filed Nov 3, 2026.